Clinical Trials in Atlanta

Showing 3241-3260 of 9,468 trials

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NCT06271252

The is a first clinical study for Oricell Therapeutics Inc. in the United States to evaluate the safety, PK, PD and preliminary efficacy of our anti-GPRC5D cell product (OriCAR-017) in subjects with relapsed/refractory multiple myeloma. RIGEL Study

Neoplasms, Plasma CellNeoplasms by Histologic TypeNeoplasms+11 more

OriCell Therapeutics Co., Ltd.81 participantsStarted Apr 2024

Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

NCT03507777

The objective of this prospective, single-blind clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy as compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and improving clinical cardiovascular outcomes in patients with high-risk clinical characteristics and/or with high-risk angiographic lesions.

Coronary Artery DiseaseCoronary StenosisAtherosclerosis+3 more

Abbott Medical Devices2,487 participantsStarted May 2018

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Burlingame, California, United States +87 more locations

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Find Trials by Condition in Atlanta

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

The clonoSEQ® Watch Registry

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Episealer® Knee System IDE Clinical Study

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Comparative Effectiveness of FITs With Colonoscopy

A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)